ASA Endorses Medical Controlled Substances Transportation Act of 2022

The American Society of Anesthesiologists (ASA) has formally announced its support of the  H.R. 7259, the Medical Controlled Substances Transportation Act of 2022, authored by Congressman Pete Sessions (R-TX-17). The bill would enable physicians to more easily transport controlled substances safely and legally across state lines. ASA sent a formal communication to Representative Sessions thanking him for his leadership on this issue.

If enacted, the legislation would represent an important step in permitting office-based anesthesiologists to administer medications at multiple practice locations. Current Drug Enforcement Administration (DEA) regulations require that a separate registration be obtained for each principal place of business or professional practice where controlled substances are manufactured, distributed, or dispensed with some exceptions. H.R. 7259 would provide clarity on this rule and ease the increasingly common practice of using controlled substances in multiple practice locations.

ASA looks forward to working with Representative Sessions for consideration and passage of this important legislation.